MHRA CLASS 1 MEDICAL DEVICE
BS EN 14476 - Virucidal efficacy test
BS EN 13727 - Bactericidal efficacy test
BS EN 13624 - Fungicidal efficacy test
BS EN 14476 - Virucidal efficacy test
BS EN 13727 - Bactericidal efficacy test
BS EN 13624 - Fungicidal efficacy test
The MHRA, the UK Medicines & Healthcare Products Regulatory Agency, has approved Amatorus as a Class 1 Medical Device.
The cost of wound infections in the US varies depending on the type and location of the wound, but overall estimates for all wound types range from $28.1 to $96.8 billion annually in Medicare spending alone.
At Amatorus, our mission is to provide healthcare professionals with innovative, high-quality anti-bacterial and anti-viral products. We focus on protecting patients from bacterial infections, antibiotic resistance, and viral transmission through advanced medical device solutions.
Amatorus has achieved MHRA medical class 1 approval. It contains no chemicals and is the worlds first product to protect against the virus!
It took over two years to develop a formulation that performed to the level required to pass the quoted BS EN tests whilst also maintaining “safe for intended use” credentials.